Dr Stephanie Sara Richard, MD | |
830 W Bayou Pines Dr, Lake Charles, LA 70601-7097 | |
(337) 436-9557 | |
(337) 312-1311 |
Full Name | Dr Stephanie Sara Richard |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 22 Years |
Location | 830 W Bayou Pines Dr, Lake Charles, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376582676 | NPI | - | NPPES |
209946701 | Medicaid | TX | |
1056081 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD.026043 (Louisiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Pathology Laboratory, Inc. | 0941240782 | 5 |
News Archive
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.
For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.
A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.
› Verified 5 days ago
Entity Name | Pathology Group Of Louisiana, A Professional Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093843450 PECOS PAC ID: 6507856317 Enrollment ID: O20040514000007 |
News Archive
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.
For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.
A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.
› Verified 5 days ago
Entity Name | The Pathology Laboratory, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215917588 PECOS PAC ID: 0941240782 Enrollment ID: O20050511000192 |
News Archive
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.
For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.
A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephanie Sara Richard, MD 830 W Bayou Pines Dr, Lake Charles, LA 70601-7097 Ph: (337) 436-9557 | Dr Stephanie Sara Richard, MD 830 W Bayou Pines Dr, Lake Charles, LA 70601-7097 Ph: (337) 436-9557 |
News Archive
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.
For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.
People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.
Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.
A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.
› Verified 5 days ago
Dr. Robert L Rumsey, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 W Bayou Pines Dr, Lake Charles, LA 70601 Phone: 337-436-9557 Fax: 337-312-1311 | |
Dr. Lehrue Stevens Jr., MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 830 Bayou Pines Dr, The Pathology Laboratory, Lake Charles, LA 70601 Phone: 337-436-9557 Fax: 337-439-3085 | |
Dr. Brandi J Kelly, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 W Bayou Pines Dr, Lake Charles, LA 70601 Phone: 337-436-9557 Fax: 337-312-1311 | |
Dr. Regina Saretta Burton, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 W Bayou Pines Dr, Lake Charles, LA 70601 Phone: 337-436-9557 | |
Gault Henry Townsend, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 830 Bayou Pines Dr, The Pathology Laboratory, Lake Charles, LA 70601 Phone: 337-436-9557 Fax: 337-439-3085 | |
Carl Gregory Bowling, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1701 Oak Park Blvd, Lake Charles, LA 70601 Phone: 337-494-3190 Fax: 337-494-2464 |